Stada Arzneimittel AG - Company Profile
Powered by 
All the sales intelligence you need on Stada Arzneimittel AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Stada Arzneimittel AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Stada Arzneimittel AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Business Description
Stada Arzneimittel AG (Stada), a subsidiary of Nidda Healthcare GmbH, (Stada) is a manufacturer of consumer healthcare, generics, and specialty pharmaceutical products. The company has also established strategic partnerships and alliances with various organizations to enhance its capabilities and expand its product portfolio. It serves patients, doctors, pharmacies, hospitals, wholesalers, and other service providers in the health care market, or private insurance companies. The company offers its product through a network of sales offices, alliance partners, distributors, and retail stores in over 100 countries globally. The company markets its products under the brand name of Nizoral, Zoflora, Grippostad, Silomat and Hirudoid.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Stada's R&D arm focuses on the development of innovative products related to neurology and nephrology, including advanced Parkinson’s disease, multiple sclerosis, and immunoglobulin A nephropathy (IgAN). The company is currently focused on the introduction of seven biosimilar and four innovative treatments. Its R&D efforts also aim to expand the generics and branded product business and explore additional growth opportunities, including non-regulated and niche markets, driven by innovative products. In FY2025, it introduced 1,291 new products to market and concluded 97 in-licensing agreements for future product launches. More than 2,500 approval procedures for over 200 APIs and combinations in more than 60 countries strengthen pipeline and enable faster international roll-out of proven brands. The company operates R&D centers in Serbia and the UK. It also operates development centers in Austria, Germany, Czech Republic, and Vietnam.
Business Segments
Overview
Offers non-prescription products, such as over-the-counter medicines, medical devices, cosmeceuticals and cosmetics, vitamins, minerals, supplements, and certain consumer products such as household disinfectants. Consumer health categories include cough and cold; derma; pain and relief; gastro; vitamins, minerals, supplements; and other CHC. Brands include Nizoral, Zoflora, Paracetamol STADA, Essentiale and Hirudoid.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers prescription drugs sold under their International Non-Proprietary Name (INN). It also offers certain other products, such as CMO sales of APIs or wholesale goods sold by certain affiliates. Therapy areas include nervous system and pain; cardiovascular; alimentary tract and metabolism; antiinfectives; urology and sex hormones; musculoskeletal system; and respiratory system. Sold through pharmacies and hospitals. Brands include Tilidine, Amoxi-Clavulane, Atorvastatin, Pantoprazole, Ezetimibe, Ezetimibe, Olmesartan, Candesartan, Bisoprolol, and Rosuvastatin, among others.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers treatment for chronic, complex, or rare conditions. They have specific requirements for prescribing, administration, distribution, storage, and pharmacovigilance . Brands include Silapo, Uzpruvo, Hukyndra, Lecigon, Oyavas, Movymia and Ocrevus,
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer